166 related articles for article (PubMed ID: 34684792)
21. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
[TBL] [Abstract][Full Text] [Related]
22. p53 autoantibodies as potential detection and prognostic biomarkers in serous ovarian cancer.
Anderson KS; Wong J; Vitonis A; Crum CP; Sluss PM; Labaer J; Cramer D
Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):859-68. PubMed ID: 20200435
[TBL] [Abstract][Full Text] [Related]
23. Serum p53 antibodies in correlation to other biological parameters of breast cancer.
Sangrajrang S; Arpornwirat W; Cheirsilpa A; Thisuphakorn P; Kalalak A; Sornprom A; Soussi T
Cancer Detect Prev; 2003; 27(3):182-6. PubMed ID: 12787724
[TBL] [Abstract][Full Text] [Related]
24. Serum anti-p53 autoantibodies in pleural malignant mesothelioma, lung cancer and non-neoplastic lung diseases.
Neri M; Betta P; Marroni P; Filiberti R; Cafferata M; Mereu C; Ivaldi G; Montanaro F; Puntoni R; Paganuzzi M
Lung Cancer; 2003 Feb; 39(2):165-72. PubMed ID: 12581569
[TBL] [Abstract][Full Text] [Related]
25. Circulating antibodies against p53 protein in patients with ovarian carcinoma. Correlation with clinicopathologic features and survival.
Angelopoulou K; Rosen B; Stratis M; Yu H; Solomou M; Diamandis EP
Cancer; 1996 Nov; 78(10):2146-52. PubMed ID: 8918407
[TBL] [Abstract][Full Text] [Related]
26. Detection of p53 auto-antibodies in the sera of breast cancer patients with a new recurrence using an ELISA assay. Does a correlation with the recurrence free interval exist?
Regidor PA; Regidor M; Callies R; Schindler AE
Eur J Gynaecol Oncol; 1996; 17(3):192-9. PubMed ID: 8780917
[TBL] [Abstract][Full Text] [Related]
27. Analysis of p53 serum antibodies in patients with head and neck squamous cell carcinoma.
Bourhis J; Lubin R; Roche B; Koscielny S; Bosq J; Dubois I; Talbot M; Marandas P; Schwaab G; Wibault P; Luboinski B; Eschwege F; Soussi T
J Natl Cancer Inst; 1996 Sep; 88(17):1228-33. PubMed ID: 8780633
[TBL] [Abstract][Full Text] [Related]
28. Anti-p53 antibodies in sera from patients with chronic obstructive pulmonary disease can predate a diagnosis of cancer.
Trivers GE; De Benedetti VM; Cawley HL; Caron G; Harrington AM; Bennett WP; Jett JR; Colby TV; Tazelaar H; Pairolero P; Miller RD; Harris CC
Clin Cancer Res; 1996 Oct; 2(10):1767-75. PubMed ID: 9816128
[TBL] [Abstract][Full Text] [Related]
29. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
[TBL] [Abstract][Full Text] [Related]
30. Detection of serum p53 antibodies from Chinese patients with papillary thyroid carcinoma using phage-SP-ELISA: correlation with clinical parameters.
Pan P; Han X; Li F; Fu Q; Gao X; Sun H; Wang L
Endocrine; 2014 Nov; 47(2):543-9. PubMed ID: 24682740
[TBL] [Abstract][Full Text] [Related]
31. Titration of serum p53 antibodies in patients with gastric cancer: a single-institute study of 40 patients.
Shimizu K; Ueda Y; Yamagishi H
Gastric Cancer; 2005; 8(4):214-9. PubMed ID: 16328595
[TBL] [Abstract][Full Text] [Related]
32. Serum antibodies against p53 in relation to cancer risk and prognosis in breast cancer: a population-based epidemiological study.
Lenner P; Wiklund F; Emdin SO; Arnerlöv C; Eklund C; Hallmans G; Zentgraf H; Dillner J
Br J Cancer; 1999 Feb; 79(5-6):927-32. PubMed ID: 10070892
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of serum p53 antibody according to KRAS status in metastatic colorectal cancer patients.
Daitoku N; Miyamoto Y; Sakamoto Y; Tokunaga R; Hiyoshi Y; Nagai Y; Iwatsuki M; Iwagami S; Yoshida N; Baba H
Int J Clin Oncol; 2020 Apr; 25(4):651-659. PubMed ID: 31834556
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of p53 mutations in non-small cell lung cancer: a meta-analysis of 829 cases from eight published studies.
Huncharek M; Kupelnick B; Geschwind JF; Caubet JF
Cancer Lett; 2000 May; 153(1-2):219-26. PubMed ID: 10779652
[TBL] [Abstract][Full Text] [Related]
35. The prognostic role of p53 mutations in metastatic colorectal cancer: A systematic review and meta-analysis.
Ottaiano A; Santorsola M; Capuozzo M; Perri F; Circelli L; Cascella M; Ianniello M; Sabbatino F; Granata V; Izzo F; Iervolino D; Casillo M; Petrillo N; Gualillo O; Nasti G; Savarese G
Crit Rev Oncol Hematol; 2023 Jun; 186():104018. PubMed ID: 37150312
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of serum p53 antibodies in squamous cell carcinoma of the lung.
Komiya T; Hirashima T; Takada M; Masuda N; Yasumitsu T; Nakagawa K; Hosono Y; Kikui M; Tsuji S; Fukuoka M; Kawase I
Anticancer Res; 1997; 17(5B):3721-4. PubMed ID: 9427768
[TBL] [Abstract][Full Text] [Related]
37. Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma.
Shimada H; Takeda A; Arima M; Okazumi S; Matsubara H; Nabeya Y; Funami Y; Hayashi H; Gunji Y; Suzuki T; Kobayashi S; Ochiai T
Cancer; 2000 Oct; 89(8):1677-83. PubMed ID: 11042560
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of serum p53 antibodies in oral cancer.
Sainger RN; Shah MH; Desai AA; Shukla SN; Shah PM; Telang SD; Patel PS
Tumori; 2006; 92(2):134-9. PubMed ID: 16724693
[TBL] [Abstract][Full Text] [Related]
39. The Significance of Combined Measurement of p53 Antibody and other Tumor Markers for Colorectal Cancer after Curative Resection.
Kawahara D; Fujita F; Hayashi H; Matsuyama T; Eguchi S
Hepatogastroenterology; 2015 May; 62(139):624-8. PubMed ID: 26897942
[TBL] [Abstract][Full Text] [Related]
40. The role of p53 on survival of upper urinary tract urothelial carcinoma: a systematic review and meta-analysis.
Ku JH; Byun SS; Jeong H; Kwak C; Kim HH; Lee SE
Clin Genitourin Cancer; 2013 Sep; 11(3):221-8. PubMed ID: 23357513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]